Effect of Metformin on Patients With Polycystic Ovary Syndrome
Not Applicable
Completed
- Conditions
- PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
- Interventions
- First Posted Date
- 2023-04-06
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 95
- Registration Number
- NCT05802212
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China
Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer
Not Applicable
Not yet recruiting
- Conditions
- Stereotactic Body RadiotherapyEarly Lung Cancer
- Interventions
- Radiation: SBRT
- First Posted Date
- 2023-04-06
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05802654
- Locations
- 🇨🇳
Department of radiation oncology, Peking University Third Hospital, Peking, Beijing, China
Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung Cancer
Active, not recruiting
- Conditions
- FractionationLung CancerStereotactic Body RadiotherapyRadiotherapy
- Interventions
- Radiation: SBRT
- First Posted Date
- 2023-04-06
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05802641
- Locations
- 🇨🇳
Department of radiation oncology, Peking University Third Hospital, Peking, Beijing, China
A Cohort Study of Correlation Between Mast Cells and Prognosis in Patients With Acute Myocardial Infarction
Not yet recruiting
- Conditions
- InflammationAcute ST Segment Elevation Myocardial InfarctionPrognosis
- Interventions
- Diagnostic Test: Tryptase
- First Posted Date
- 2023-04-06
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05802667
Effectiveness of Yunnan Baiyao in Improving Fracture Pain
Not Applicable
Not yet recruiting
- Conditions
- Distal Radius Fracture
- Interventions
- Drug: Yunnan BaiyaoDrug: Celecoxib 200mg
- First Posted Date
- 2023-03-13
- Last Posted Date
- 2023-03-13
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 58
- Registration Number
- NCT05765747
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China
Study on the Development of Neonatal Cerebral Blood Flow Based on Ultrafast Ultrasound Doppler Imaging
Recruiting
- Conditions
- Premature Birth
- Interventions
- Diagnostic Test: ultrafast ultrasound power Doppler imaging
- First Posted Date
- 2023-03-09
- Last Posted Date
- 2023-03-09
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT05761548
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients
Phase 4
Recruiting
- Conditions
- Chronic Kidney Disease
- Interventions
- Drug: Midazolam, dabigatran etexilate, pitavastatin, rosuvastatin and atorvastatin
- First Posted Date
- 2023-02-28
- Last Posted Date
- 2023-02-28
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT05747768
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China
A Prediction Model and Assisted Decision-making System of Fertilization Disorders
Not Applicable
Recruiting
- Conditions
- Infertility
- Interventions
- Diagnostic Test: Accurate prediction of fertilization disorders and clinical decision support systems assist doctors in decision-makingDiagnostic Test: Clinicians follow a routine protocol
- First Posted Date
- 2023-02-16
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 260
- Registration Number
- NCT05730764
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy and the Preventive of Probiotics
Phase 4
Not yet recruiting
- Conditions
- Cancer Therapy-related Cardiovascular Toxicity
- Interventions
- First Posted Date
- 2023-02-16
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT05730777
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, China
Correlation Between Myocardial Injury and Intestinal Flora Changes Associated With Oncology Drug Therapy
Recruiting
- Conditions
- Cancer Therapy-related Cardiovascular Toxicity
- Interventions
- Drug: Antitumor drugs
- First Posted Date
- 2023-02-15
- Last Posted Date
- 2023-03-03
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT05728788
- Locations
- 🇨🇳
Zhenyu Tian, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath